I'm trying to recall the timeline, quite frankly, concerning when the actual report was published, because the event was in 2014, which is around the same time as the parliamentary motion. I wasn't personally involved in the design of the program, but I know that at the time of doing so it is typical to do as much research and international scanning as possible, and then at the end of the day a decision is made.
We have looked at that report since. I think I may not be up to date, after hearing Dr. Vargesson today—there are constantly more developments—but to my understanding there are about 13 or 14 conditions that present in similar ways to thalidomide and can't be ruled out through genetic testing.
We are keeping an eye on this as well. We have had recent discussions with the U.K.'s Thalidomide Trust—just as recently as last week, actually—and they confirmed that the algorithm hasn't been proven or verified yet. They're very hopeful. It still is just a probability, not a definitive test, but we constantly keep our eyes open for emerging science.